BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7069423)

  • 1. The noradrenergic system in Alzheimer and multi-infarct dementias.
    Mann DM; Yates PO; Hawkes J
    J Neurol Neurosurg Psychiatry; 1982 Feb; 45(2):113-9. PubMed ID: 7069423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological basis for neurotransmitter changes in Parkinson's disease.
    Mann DM; Yates PO
    Neuropathol Appl Neurobiol; 1983; 9(1):3-19. PubMed ID: 6133229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the monoamine containing neurones of the human CNS in senile dementia.
    Mann DM; Lincoln J; Yates PO; Stamp JE; Toper S
    Br J Psychiatry; 1980 Jun; 136():533-41. PubMed ID: 6155966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease.
    Bondareff W; Mountjoy CQ; Roth M; Rossor MN; Iversen LL; Reynolds GP; Hauser DL
    Alzheimer Dis Assoc Disord; 1987; 1(4):256-62. PubMed ID: 3453748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological changes in Alzheimer's disease-senile dementia: ultrastructural changes and quantitative studies.
    Terry RD
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():99-105. PubMed ID: 419338
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell loss in the locus coeruleus in senile dementia of Alzheimer type.
    Tomlinson BE; Irving D; Blessed G
    J Neurol Sci; 1981 Mar; 49(3):419-28. PubMed ID: 7217992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type.
    Mann DM; Yates PO; Marcyniuk B
    Clin Neuropathol; 1984; 3(5):199-205. PubMed ID: 6499296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaques and tangles and transmitter deficiencies in dementia.
    Mann DM; Yates PO; Hawkes J
    J Neurol Neurosurg Psychiatry; 1982 Jun; 45(6):563-4. PubMed ID: 6214616
    [No Abstract]   [Full Text] [Related]  

  • 10. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia.
    Matthews KL; Chen CP; Esiri MM; Keene J; Minger SL; Francis PT
    Biol Psychiatry; 2002 Mar; 51(5):407-16. PubMed ID: 11904135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of clinical diagnosis in dementia: a prospective clinicopathological study.
    Mölsä PK; Paljärvi L; Rinne JO; Rinne UK; Säkö E
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1085-90. PubMed ID: 4078573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.
    Bondareff W; Mountjoy CQ; Roth M
    Lancet; 1981 Apr; 1(8223):783-4. PubMed ID: 6110985
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholamine neurons with Alzheimer's neurofibrillary changes and alteration of tyrosine hydroxylase. Immunohistochemical investigation of tyrosine hydroxylase.
    Nakashima S; Ikuta F
    Acta Neuropathol; 1985; 66(1):37-41. PubMed ID: 2859729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.
    Gannon M; Wang Q
    Brain Res; 2019 Jan; 1702():12-16. PubMed ID: 29307592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():125-35. PubMed ID: 2411933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus ceruleus degeneration is ubiquitous in Alzheimer's disease: possible implications for diagnosis and treatment.
    Haglund M; Sjöbeck M; Englund E
    Neuropathology; 2006 Dec; 26(6):528-32. PubMed ID: 17203588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.
    Bondareff W; Mountjoy CQ; Roth M
    Neurology; 1982 Feb; 32(2):164-8. PubMed ID: 7198741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathologic anatomy of senile dementia of the Alzheimer type].
    Probst A
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(4):97-8. PubMed ID: 2413544
    [No Abstract]   [Full Text] [Related]  

  • 19. Early-onset dementia and extrapyramidal disease: clinicopathological variant of Gerstmann-Straussler-Scheinker or Alzheimer's disease?
    Hart J; Gordon B
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):932-4. PubMed ID: 2283522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit.
    Mann DM; Yates PO; Marcyniuk B
    Clin Neuropathol; 1985; 4(3):127-34. PubMed ID: 3160517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.